<strong>Report</strong> on the Distribution of the Community's contributionType of Instrument NoE Project Title (or Acronym) <strong>EURASNET</strong> Contract N° 518238Part II Distribution of the Community's prefinancing (or payment) between contractors according to the consortium decision(s) (4)<strong>Report</strong>ing Period 1 <strong>Report</strong>ing Period 2 <strong>Report</strong>ing Period 3 <strong>Report</strong>ing Period 4 <strong>Report</strong>ing Period 5 <strong>Report</strong>ing Period 6 <strong>Report</strong>ing Period 7 Final paymentContractorn°Total (Y)Organisation ShortNameCountryCode23 UCAM-DBIOC UK24 HUJI IL25 IGMBC-GIE FR26 INSERM FR27 FCSR IT28 ISB-SIB CH29 ETHZ CH30 IIMCB PL31 UPF ES32 SOTON-HGD UKDate(s) (5)Amount(s)(A') (5)Date(s) (5)Amount(s)(B') (5)Date(s) (5)Amount(s)(C') (5)Date(s) (5)Amount(s)(D') (5)Date(s) (5)27.01.2006 51.000,00 21.04.<strong>2008</strong> 40.000,00 91.000,0028.11.2006 16.000,00 16.000,008.12.2006 4.500,00 4.500,000,00Total 71.500,00 Total 0,00 Total 40.000,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 111.500,0027.01.2006 51.000,00 21.04.<strong>2008</strong> 40.000,00 91.000,000,000,000,00Total 51.000,00 Total 0,00 Total 40.000,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 91.000,0027.01.2006 51.000,00 21.04.<strong>2008</strong> 40.000,00 91.000,000,000,000,00Total 51.000,00 Total 0,00 Total 40.000,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 91.000,0021.07.2006 34.000,00 21.04.<strong>2008</strong> 40.000,00 74.000,0022.12.<strong>2008</strong> 27.728,18 27.728,180,000,00Total 34.000,00 Total 0,00 Total 67.728,18 Total 0,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 101.728,1828.08.2006 34.000,00 21.04.<strong>2008</strong> 40.000,00 74.000,000,000,000,00Total 34.000,00 Total 0,00 Total 40.000,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 74.000,0021.07.2006 34.000,00 21.04.<strong>2008</strong> 40.000,00 74.000,000,000,000,00Total 34.000,00 Total 0,00 Total 40.000,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 74.000,0021.04.<strong>2008</strong> 17.000,00 17.000,000,000,000,00Total 0,00 Total 0,00 Total 17.000,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 17.000,0021.04.<strong>2008</strong> 17.000,00 17.000,000,000,000,00Total 0,00 Total 0,00 Total 17.000,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 17.000,0021.04.<strong>2008</strong> 17.000,00 17.000,000,000,000,00Total 0,00 Total 0,00 Total 17.000,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 17.000,0021.04.<strong>2008</strong> 17.000,00 17.000,000,000,000,00Total 0,00 Total 0,00 Total 17.000,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 17.000,00Total 2.318.742,69 Total 165.788,50 Total 2.033.188,90 Total 0,00 Total 0,00 Total 0,00 Total 0,00 Total 0,00 4.517.720,09Amount(s)(E') (5)Date(s) (5)Amount(s)(F') (5)Date(s) (5)Amount(s)(G') (5)Date(s) (5)Amount(s)(H') (5)Total Amount(I') (6)Part IIIDifference between Community's prefinancing (or payment) sent to the coordinator and Total Distribution of the Community's prefinancing (or payment) between contractors according to the consortiumdecision(s) (4)<strong>Report</strong>ing Period 1 <strong>Report</strong>ing Period 2 <strong>Report</strong>ing Period 3 <strong>Report</strong>ing Period 4 <strong>Report</strong>ing Period 5 <strong>Report</strong>ing Period 6 <strong>Report</strong>ing Period 7 Final paymentTotal AmountCommunity's prefinancing (or payment) not yetdistributed between contractors (Z) (7)231257,31 -165788,50 1956874,180,00 0,00 0,00 0,000,002022342,99I certify that the information set out in this(these) form(s) is accurate and correct and agreed by all contractors.Name (8) Surname (8)Date(dd/mm/yyyy)Signature of the administrative official authorised to commit the organisation of the coordinator (8)MANFREDMESSERSCHMIDT205Explanatory notes Page n° / 3(1): To be filled in only by the coordinator. (2): Established in conformity with articles 4.2 and 6 of the contract.(3): (I) = (A) + (B) + (C) + (D) + (E) + (F) + (G) + (H) (4): To be filled in only by the coordinator.(5): Insert the dates (dd/mm/yyyy) and the amounts (x,xxx.xx !) transferred to a contractor (including the coordinator) for a reporting period. If there are more than one transfer to a contractor during a reporting period, identify each date and each relating transferred amount.(6): (I') = (A') + (B') + (C') + (D') + (E') + (F') + (G') + (H') (7): (Z) = (X) - (Y)(8): One the following persons : authorised contact person or first or second administrative official authorised to sign the contract, as mentioned in your Contract Preparation Form (Form A2b)3
14 SUMMARY EXPLANATION OF THE IMPACT OF MAJOR DEVIATIONSFROM COST AND PERSON MONTH BUDGETThe EC payment for 2007 was received in April <strong>2008</strong> only and was immediately distributed to members. The ECpayment for <strong>2008</strong> has been received December 31, <strong>2008</strong>. It could therefore be distributed only in January 2009.The REPORT ON THE DISTRIBUTION OF THE COMMUNITY'S CONTRIBUTION (Section 13) thereforeshows a non-distributed amount of 1.956.874,18 Euro. This does therefore not constitute underspending.Transfers from the Coordinator's escrow account made in <strong>2008</strong> are listed in the justification of major cost itemsfor participant 1a (coordinator). Eurasnet partner Stefan Stamm (#3) receives money until the end of February<strong>2008</strong> (the termination of his status as Eurasnet member). Stefan Stamm continued to work on <strong>EURASNET</strong>deliverables during all of <strong>2008</strong> and will continue to work on the completion of his deliverables of the JPA month25-42. Future PMs originally assigned to him will be shouldered by other network members. We thereforeinclude in this <strong>Report</strong> <strong>2008</strong> an updated table PM Efforts for the full duration of the project (Section 15.9) whichshows how the PM have been redistributed. Due to the unclear situation of his status he did not receive fundsduring 2007/<strong>2008</strong> and his final payment will be made in 2009 only (that is balancing and closing his Erlangenaccount with the date Feb 29, <strong>2008</strong>). The research funds assigned to University Erlangen (Stefan Stamm) inAnnex I remain under the control of the coordinator and will be distributed for tasks previously assigned to St.Stamm following case by case decisions. As already mentioned in our 2007 <strong>Annual</strong> <strong>Report</strong>, the website-relatedtasks and connected funds were switched to Eurasnet member John Brown (#14) effective July 1, 2007. Thishappened also in anticipation of a possible move of Stefan Stamm. An amendment request addressing theleaving of Stefan Stamm is submitted with this <strong>Annual</strong> <strong>Report</strong> <strong>2008</strong>.Steering Committee and Coordinator hold the firm opinion that the contact to clinical practitioners is of highestimportance to establish the awareness of the connections of alternative splicing and disease processes in themedical community. In this view we are supported by our Scientific Advisory Board. As already pointed out inour reply letter to the 2007 Reviewer's <strong>Report</strong>, <strong>EURASNET</strong> is striving to give this connection to practitioner anddiagnosis a stronger standing within the framework of <strong>EURASNET</strong>. <strong>EURASNET</strong> therefore decided inNovember <strong>2008</strong> to support a proposal brought forth by Eurasnet partner 32 Diana Baralle, University ofSouthampton. In a flagship study in cooperation with the National Genetics Reference Laboratory, UK Eurasnetwill explore the needs, technical aspects and quality assurance of RNA analysis as a means of interpretingsequence variants. Principal investigator for this study is Diana Baralle. Eurasnet supports this study with 60.000Euros for a one year scientist position. These funds originate from money saved during the cost-efficientorganisation of workshops and meetings and in particular the cost-efficient operation of the <strong>EURASNET</strong>website.Partner 32 does not claim eligible costs for <strong>2008</strong>. The explanation is given in the justification section 10.32.15 JOINT PROGRAM OF ACTIVITIES (MONTH 25-42, JAN <strong>2008</strong>-JUNE 2009)15.1 THE FUTURE OF <strong>EURASNET</strong> RESEARCH: GOALS AND OBJECTIVESAFTER TWO YEARSTwo years into the network, <strong>EURASNET</strong> thought it appropriate to reconsider its goals and perspectives, itsapproaches and structures. To this purpose the coordinator convened a PI-only session during the IFM onBiophysical Methods, Berlin January <strong>2008</strong>. Taking into consideration achievements and deficits of the last twoyears, surveying the rapidly evolving field of alternative splicing with many new technologies and researchoptions emerging, network members discussed where new avenues of research should be ventured and whereoutdated goals should be abandoned.206
- Page 3 and 4:
TABLE OF CONTENTSA. PERIODIC ACTIVI
- Page 5 and 6:
1 PUBLISHABLE EXECUTIVE SUMMARY EUR
- Page 7 and 8:
Dr. Davide Gabellini(28) Swiss Inst
- Page 9 and 10:
WP7 Molecular characterization of s
- Page 11 and 12:
To identify protein-protein interac
- Page 13 and 14:
expressed in a particular tissue. T
- Page 15 and 16:
Duchenne muscular dystrophy (DMD).
- Page 17 and 18:
WP21 Reachout to the broader RNA co
- Page 19 and 20:
4.1 TABLE OF MILESTONES JPA MONTH 2
- Page 21 and 22:
Numerous plasmids, constructs, extr
- Page 23 and 24:
collaboration between EURASNET and
- Page 25 and 26:
5.1 WORK PACKAGE REPORTSWork Packag
- Page 27 and 28:
• Ongoing regular addition of new
- Page 29 and 30:
Work Package 4 The Alternative Spli
- Page 31 and 32:
Work Package 6 In silico approaches
- Page 33 and 34:
alternative splicing.162 Compare sp
- Page 35 and 36:
33 Agreement on pre-mRNA substrates
- Page 37 and 38:
its numerous binding sites on both
- Page 39 and 40:
Work Package 8 Genome-wide Analyses
- Page 41 and 42:
173 Further development of data ana
- Page 43 and 44:
Problems and explanations for delay
- Page 45 and 46:
eveal that there is a dramatic chan
- Page 47 and 48:
Work Package 10 Post-translational
- Page 49 and 50:
mutational analysis that led to the
- Page 51 and 52:
Isolation of an active step I splic
- Page 53 and 54:
FBP11 and 21 with these sequences.
- Page 55 and 56:
Similarly to what observed for SF2/
- Page 57 and 58:
prp45-113 mutant, which is compatib
- Page 59 and 60:
cell lines. In contrast in the pres
- Page 61 and 62:
genes with roles in the development
- Page 63 and 64:
Structural analyses of several RRMs
- Page 65:
Work Package 17 Staff Exchange and
- Page 69 and 70:
Barralle's lab, Krämer is acting a
- Page 71 and 72:
alternative splicing) and higher ed
- Page 73 and 74:
Student Symposium “Decision Makin
- Page 75 and 76:
variation and suitability for use w
- Page 77 and 78:
Following feedback from members we
- Page 79 and 80:
Invited seminars: In addition to me
- Page 81 and 82:
Publications 2008Author Title Publi
- Page 83 and 84:
Author Title Publication EURASNET P
- Page 85 and 86:
Author Title Publication EURASNET P
- Page 87 and 88:
Author Title Publication EURASNET P
- Page 89 and 90:
Author Title Publication EURASNET P
- Page 91 and 92:
Author Title Publication EURASNET P
- Page 93 and 94:
Minutes of the General Assembly dec
- Page 96 and 97:
241 Evaluate available careerdevelo
- Page 98 and 99:
156 The EURASNET memberStamm publis
- Page 100 and 101:
y coarse-grained foldingsimulation.
- Page 102 and 103:
overexpressor and mutant lines(mont
- Page 104 and 105:
machinery with particularrespect to
- Page 106 and 107:
alternative splicing, using theEDI
- Page 108 and 109:
contemporary findings withinthe EUR
- Page 110 and 111:
Author Title Publication EURASNET P
- Page 112 and 113:
Author Title Publication EURASNET P
- Page 114 and 115:
Author Title Publication EURASNET P
- Page 116 and 117:
Author Title Publication EURASNET P
- Page 118 and 119:
Licht K, Medenbach J, Lührmann R,K
- Page 120 and 121:
Author Title Publication EURASNET P
- Page 122 and 123:
9 TABULAR OVERVIEW OF MAJOR COST IT
- Page 124 and 125:
total costs * 18.891,12 52778.60 41
- Page 126 and 127:
other (the rest) 48,57 0 56.539,43t
- Page 128 and 129:
travel 6.964,91overhead 3.081,07oth
- Page 130 and 131:
Participant 1A Type of expenditure
- Page 132 and 133:
Participant 1B - Karla Neugebauera)
- Page 134 and 135:
Participant 2 - Juan Valcarcela) Wo
- Page 136 and 137:
Participant 3 - Stefan Stamma) Work
- Page 138 and 139:
Participant 4 - Göran Akusjärvia)
- Page 140 and 141:
Participant 5A/B - Peer Bork/Rolf A
- Page 142 and 143:
Major cost items• ResearchPersonn
- Page 144 and 145:
Participant 7 - Francisco Barallea)
- Page 146 and 147:
Francisco Baralle gave a talk to a
- Page 148 and 149:
alternative splicing on human disea
- Page 150 and 151:
J. Beggs has had frequent contact w
- Page 152 and 153:
Major cost items• ResearchPersonn
- Page 154 and 155:
Major cost items• ResearchPersonn
- Page 156 and 157: Participant 12A - Jamal Tazia) Work
- Page 158 and 159: Participant 12B - Bertrand Séraphi
- Page 160 and 161: Participant 12C - Christiane Branla
- Page 162 and 163: Participant 12D - Edouard Bertranda
- Page 164 and 165: Participant 13 - Daniel Schümperli
- Page 166 and 167: Participant 14 - John W. S. Browna)
- Page 168 and 169: Participant 15 - Javier F. Cáceres
- Page 170 and 171: • ResearchPersonnelName WP Person
- Page 172 and 173: MiscellaneousOligonucleotidesUse of
- Page 174 and 175: Major cost items• ResearchConsuma
- Page 176 and 177: Major cost items• ResearchPersonn
- Page 178 and 179: Participant 21 - Angela Krämera) W
- Page 180 and 181: Participant 22 - Angus Lamonda) Wor
- Page 182 and 183: Participant 23 - Chris Smitha) Work
- Page 184 and 185: ChemicalsEnzymesLaboratory supplies
- Page 186 and 187: Participant 26 - Didier Auboeufa) W
- Page 188 and 189: tool for the molecular analysis of
- Page 190 and 191: Participant 29 - Frédéric Allaina
- Page 192 and 193: protein and instead possesses the d
- Page 194 and 195: + overhead 4.730= total eligible co
- Page 196 and 197: Claudia Tamaro (PhD) has begun work
- Page 198 and 199: ETHZIIMCBUPFSOTON-HGDTOTALJoint Pro
- Page 200 and 201: Direct eligible costs 53.240,48 0,0
- Page 202 and 203: Direct eligible costs 18.720,07 0,0
- Page 204 and 205: 13 REPORT ON THE DISTRIBUTION OF TH
- Page 208 and 209: For most work packages here follows
- Page 210 and 211: pathways (eg, Reactome ).While PAND
- Page 212 and 213: The possible dependence of the effe
- Page 214 and 215: In some treatments or mutants, simi
- Page 216 and 217: Work Package 12: Mis-splicing and D
- Page 218 and 219: acid. Furthermore, using antibodies
- Page 220 and 221: At the 2007 annual meeting in Ile d
- Page 222 and 223: Partner 13 has extensively studied
- Page 224 and 225: inhibitors/modulators of RNA splici
- Page 226 and 227: 18 MONTH JPA: WORKPACKAGE TIMECOURS
- Page 228 and 229: 15.3 GRAPHICAL PRESENTATION OF WORK
- Page 230 and 231: 15.4 TABLE OF MILESTONES (MONTH 37-
- Page 232 and 233: 156 The EURASNET memberStamm publis
- Page 234 and 235: 194 Bertrand will analyze indetail
- Page 236 and 237: 216 Aubeouf and Neugebauer willcoll
- Page 238 and 239: 238 Establishing joint PhDcommittee
- Page 240 and 241: 283 A unified browser for allknown
- Page 242 and 243: 296 Group 12a (Branlant) willuse th
- Page 244 and 245: 315 Lamond will use a FLIM-FRET bas
- Page 246 and 247: 329 GROUP 7 (F. BARALLE)will contin
- Page 248 and 249: 333 GROUP 27 (GABELLINI)will:1) foc
- Page 250 and 251: 345 Schümperli’s group isplannin
- Page 252 and 253: 366 Quarterly network e-mail atmont
- Page 254 and 255: 2. Sharing Resources, Technology an
- Page 256 and 257:
5. Ensuring DurabilityWorkpackage d
- Page 258 and 259:
7. Molecular Characterization of Sp
- Page 260 and 261:
8. Genome-wide Analyses of Splicing
- Page 262 and 263:
9. Complexity of Spliceosomal Prote
- Page 264 and 265:
202 Srebrow will investigate the ro
- Page 266 and 267:
12. Mis-splicing and DiseaseWorkpac
- Page 268 and 269:
13. Co-transcriptional Mechanisms o
- Page 270 and 271:
14. Chemical Biology and Therapeuti
- Page 272 and 273:
15. Development of Enabling Technol
- Page 274 and 275:
269 IFMs in 20091. “Alternative a
- Page 276 and 277:
18. Career DevelopmentWorkpackage d
- Page 278 and 279:
20. SMEs and Technology TransferWor
- Page 280 and 281:
21. Reachout to the Broader RNA Com
- Page 282 and 283:
15.7 WORK PACKAGE LIST (MONTHS 37-5
- Page 284 and 285:
ETHZIIMCBUPFSOTON-HGDTOTALJoint Pro
- Page 286 and 287:
AMU 5 29 8 42UAAR 5 145 16 1665 29
- Page 288 and 289:
Joint Programme of Activities RESEA
- Page 290 and 291:
60 month period 18 month periodRequ
- Page 292 and 293:
Integration1. Young Investigator Pr
- Page 294 and 295:
UCAM-DBIOC 2350,000x1/3 € 50,000x
- Page 296:
the management team. Audit costs ar